W. D. JIN ET AL.
Discuss
On the antidepressant drug-induced phase conversion of
most of the data are retrospective, and therefore to some extent
there may be partial differences. Therefore, prospective obser-
vation may avoidance this partial differences, which can find
real switching rate under certain the conditions specified or
natural treatment condition in a certain time period of antide-
pressant therapy and can find risks related to switching. Our
results show that about 10% depressive episode patients may
switch and it often appear at about 1 month after beginning of
treatment.
Clinicians managing depression in patients with bipolar
disorder or patients who we don’t know its trait face two chal-
lenges. First, major depression is a handicapping disease and is
associated with a high risk of suicide in bipolar patients. Sec-
ond, in bipolar patients, antidepressant drugs are associated
with a high risk of antidepressant-induced mania (AIM) and
rapid cycling. The definition of predictors of AIM is a key issue
for the therapeutic management of bipolar patients. Clinical
studies on bipolar patients with and without AIM have identi-
fied characteristics with poor sensitivity and low specificity.
Many factors related to switching was found, such as family
history of bipolar disorder, early onset of disorder, hyperthemia
of Temperament, extreme personality, history of switching, and
some biological factors, such as Hypothyroidism, functional
polymorphism of the serotonin transporter (5-HTT) gene
(Rousseva et al., 2003). Also findings suggesting gender, some
clinical features (Jin et al., 2006), dysthmia and cyclothmia, or
borderline personality disorder (Ghaemi, Ko, & Goodwin,
2002,) maybe related to switching. But all these refer to bipolar
disorder. In fact, some depressive patients diagnosed as unipo-
lar depression maybe switched during treatment with antide-
pressants.
Tondo L. (2009) review available data pertaining to risk of
mania—hypomania among bipolar (BPD) and major depressive
disorder (MDD) patients with vs. without exposure to antide-
pressant drugs (ADs) and consider effects of mood stabilizers,
They computerized searching yielded 73 reports (109 trials,
114,521 adult patients); 35 were suitable for random effects
meta-analysis, and multivariate-regression modeling included
all available trials to test for effects of trial design, AD type,
and mood-stabilizer use. And found that overall risk of mania
with/without ADs averaged 12.5%/7.5%. The AD-associated
mania was more frequent in BPD than MDD patients (Tondo,
Vázquez, & Baldessarini, 2010). We also had some results. 10
of 170 unipolar depression had switched during antidepressants
therapy. It indicated that there is greater difference in switching
rate between bipolar and unipolar disorder, which was most
significant risk for switching. These patients can not be diag-
nosed as bipolar disorder by model criteria. when followed
prospectively, many adults patients with antidepressant-associ-
ated hypomania are found to progress to bipolar states with
spontaneous mania or hypomania months or years later
(Ghaemi, Ko, & Goodwin, 2002; Gao et al., 2008). So the pa-
tients with switching of mania could be diagnosed bipolar dis-
order only depending on modification of model bipolar dis-
order diagnose criteria (Jin et al., 2006; Chun & Dunner, 2004;
Gao et al., 2008).
In General, Combination usage of antidepressant may one
risk for switching (Jin, Chen, & Xing, 2007a; Gao et al., 2008),
but we don’t found this conclusion, which may be related to
short duration of observation and less cases. Many results sup-
ported that 2 or more AD combination for treatment of depres-
sive episode promoted risk of switching to mania or rapid cy-
cling. But this switching can be interrupted or reduced by mood
stabilizers, it’s risk can be reduced 50% (Bottlender et al.,
2001). In past we also found lithium carbonate can significantly
reduced switching risk in bipolar disorder (Jin X. G. & Jin W.
D., 2007). But our result can not show the same result, which
may be related more “nulpolar” depression patients who be
treated less mood stabilizer and all patient be treated less mood
stabilizer. Only 5 patients in our studied patients were con-
gratulated with mood stabilizes, which reflected therapy status
of psychiatrist in china.
Treatment of bipolar depression patients is caused for con-
cern, In general, antidepressants do not need the participation of
many bipolar depression treatment Many guidelines also em-
phasize this point. But most of the cases, the risk of bipolar
depression phase conversion was significantly higher than uni-
polar depression, almost close to half of depression may con-
verse to drug-related mania or hypomania, even rapid cycling.
Our previous study found that bipolar depression is occurred
during treatment with probability close to 40% (Song et al.,
2008), this study also suggest a similar discovery.
Different antidepressants maybe had a various switching rate
for patients with depressive episode. In general, TCA and SNRI
had more promotion to mania than that of SSRIs for depressive
patients. So bipolar depressive patients shouldn’t be treated
with antidepressants except special conditions, in which only
SSRIs was used. Some studies found that TCA and SNRI is
more than motivational than SSRI, especially for bipolar de-
pression on the types of antidepressant drugs (Peet, 1994; Ba-
rak, Kimhi, & Weizman, 2000). The switching rate of TCA was
12 times compare to citalopram (Barak, Kimhi, & Weizman,
2000), SNRI’s switching rate of SSRI 3 times compare to par-
oxetine (Peet, 1996), we do not have similar findings, which
may be and fewer cases and the observation time is short. But
more of concern is the type of depression.
REFERENCES
Akiskal, H. S. (1996). The prevalent clinical spectrum of bipolar disor-
ders: Beyond DSM-IV. Journal of Clinical Psychopharmacology, 16,
4s-14s.
Barak, Y., Kimhi, R., & Weizman, R. (2000). Is selectivity for sero-
tonin uptake associated with a reduced emergence of manic episodes
in depressed patients? International Clinical Psychopharmacology,
15, 53-56. doi:10.1097/00004850-200015010-00009
Bottlender, R., Rudolf, D., Strauss, A. et al. (2001). Mood stabilizers
reduce the risk of developing antidepressant-induced maniform state
in acute treatment of bipolar I depressed patients. Journal of Affective
Disorders, 63, 79-83. doi:10.1016/S0165-0327(00)00172-5
Chun, B. J., & Dunner, D. L. (2004). A review of antidepressant-in-
duced hypomania in major depression: Suggestions for DSM-V. Bi-
polar Disorders, 6, 32-42. doi:10.1046/j.1399-5618.2003.00084.x
Ferrier, I. N., Macmillan, I. C., & Yong, A. H. (2011). The search for
the wadering thymostat: A rewiew of some developments in bipolar
research. The British Journ al of Psychiatry, 178, s103-s106.
Gao, K., Kemp, D. E., Ganocy, S. J. et al. (2008). Treatment-emergent
mania/hypomania during antidepressant monotherapy in patients
with rapid cycling bipolar disorder. Bipolar Disorders, 10, 907-915.
doi:10.1111/j.1399-5618.2008.00637.x
Ghaemi, S. N., Ko, J. Y., & Goodwin, F. K. (2002). Cade’s disease and
beyond: Misdiagnosis, antidepressant use, and a proposed definition
for bipolar spectrum disorder. Canadian Journal of Psychiatry, 47,
Copyright © 2013 SciRes.
176